InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ElSid18 post# 332111

Saturday, 10/19/2019 7:02:07 PM

Saturday, October 19, 2019 7:02:07 PM

Post# of 346375

Today's action feels different. The upward trend is steady and the
retracements are minor..I am very encouraged by the volume as well..
COULD it be that we have actually bottomed this time??? Tune in for
more updates, girls and boys...how we close will be very telling....!



Investors buying in now, new NEW IIS even, are finding some relevant information such as how and why Merck likes PS Targeting

Ampersand Capital likes Interface Diagnostics that likes Cancer Genetics Inc that likes Keytruda Merck that likes PS Targeting that like is flipped on EVERY stressed to inflamed to cancer cell

It's all going to surface as Ampersand had to get Interface Diagnostics

Joseph Hreiki got quite the promotion from MSK David Solits lab...as Joe worked with Interpace Diagnostics and BMS and MSK only one focal point

Raju S Chagnati worked for CGI - Cancer Genetics Inc

Guess WHY Keytruda got approval? Due to CGI - Cancer Genetics Inc via Thermofisher

....nondisclosures signed by many and HTG involved ....and there is MUCH more to surface as Ampersand seems to be all about hiding PS Targeting info where CGI knew all about Bavituximab treated patients in Keytruda registrational trial boosting it's approval

The puzzle pieces are ALL going to fly in as there is entertainment looming ...

To the others, file with SEC and depositions just may lift MANY nondisclosure agreements that will make Johnny Springs Stafford possibly regret things ...and no interest in Avid CDMO / PS Targeting ? Maybe there was too much interest : ) ...as 80,000+ shares fly under the radar after hours Friday and IIS exchange shares in past
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News